Study of Monarda fistulosa essential oil as a prospective antiseborrheic agent.
Monarda fistulosa essential oil characterized by pronounced therapeutic effects is proposed for the treatment of seborrhea. Studies of its antibacterial, antimycotic, and antiinflammatory activities showed that it inhibits microorganism growth and is superior to hydrocortisone in combination with vitamin B6 by its antiinflammatory activity.
Zhilyakova
E T
ET
Belgorod State University, Russia.
Novikov
O O
OO
Naumenko
E N
EN
Krichkovskaya
L V
LV
Kiseleva
T S
TS
Timoshenko
E Yu
EY
Novikova
M Yu
MY
Litvinov
S A
SA
D000293:Adolescent; D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D012628:Dermatitis, Seborrheic / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D004357:Drug Synergism; D005658:Fungi / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy; D027523:Lavandula; D051379:Mice; D008826:Microbial Sensitivity Tests; D031338:Monarda / Q000737:chemistry*; D009822:Oils, Volatile / Q000494:pharmacology / Q000627:therapeutic use*; D010938:Plant Oils / Q000494:pharmacology / Q000627:therapeutic use*; D025101:Vitamin B 6 / Q000494:pharmacology / Q000627:therapeutic use; D055815:Young Adult
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D009822:Oils, Volatile; D010938:Plant Oils; D025101:Vitamin B 6; D006854:Hydrocortisone; C045718:lavender oil